Literature DB >> 14616668

Head-shaking nystagmus in patients with a vestibular schwannoma.

R L Humphriss1, D M Baguley, D A Moffat.   

Abstract

The aim of this study was to calculate the sensitivity of the head-shake test for peripheral and central vestibular dysfunction associated with unilateral sporadic vestibular schwannoma and to discuss the feasibility of using the head-shake test as a screening test. The study group consisted of 102 patients with unilateral sporadic vestibular schwannomas, who were seen consecutively for preoperative vestibular assessment, including the head-shake test. The sensitivity of the head-shake test for vestibular schwannoma was found to be 22%, and the sensitivity and specificity of the head-shake test for canal paresis (>/=25%) were found to be 27% and 88%, respectively. Patients with abnormalities in the central vestibular system and with a greater canal paresis were more likely to have head-shake nystagmus, although, even for severe canal paresis, the sensitivity of the test remained low at 36%. The direction of nystagmus was found to be contra-lateral to the side of the tumour in 86% of patients. It was concluded that the head-shake test is of insufficient sensitivity to be used as a screening test either for vestibular schwannoma or for vestibular-system abnormalities associated with vestibular schwannoma. The deduction is made that the head-shake test is of insufficient sensitivity or specificity to be of clinical value as a screening test for vestibular dysfunction in a general population with symptoms of imbalance.

Entities:  

Mesh:

Year:  2003        PMID: 14616668     DOI: 10.1046/j.1365-2273.2003.00753.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  1 in total

1.  Clinical Predictors of Streptomycin-Vestibulotoxicity.

Authors:  Miraj Ahmed; Anupam Mishra; Kamal Kumar Sawlani; Veerendra Verma; Rajiv Garg; Hitendra Prakash Singh; Sunil Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-12-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.